|
|
 |
ALUMINUM HYDROXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BENZETHONIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ISENTRESS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIUM GLYCYRRHIZATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INREBIC Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INTRAROSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ISOPROPYL PALMITATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INVOKANA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|